Killed-Virus Vaccine Results
The results of the killed-virus vaccine developed by Salk were groundbreaking. In fact, the vaccine was licensed on the same day the results were released. This remarkable vaccine brought about a significant change in the number of polio cases. Just two years after its release, in 1957, the annual polio cases dropped drastically from 58,000 to 5,600. The impact of the vaccine continued to be felt as by 1961, only 161 cases were reported.
Salk strongly believed that his vaccine should be readily accessible to all, as he understood that the only way to eradicate polio was to ensure that everyone could receive the vaccination. To achieve this goal, six pharmaceutical companies were involved in the production of Salk’s vaccine. It is worth noting that Salk did not seek personal financial gain from sharing the process.
Dr. Albert Sabin: Revolutionizing Polio Prevention
Dr. Albert Sabin, a renowned medical researcher, played a pivotal role in the development of an oral polio vaccine. During the same period when Dr. Jonas Salk was working on his killed-virus vaccine, Dr. Sabin had a different approach in mind. He believed that an oral vaccine would be more convenient and practical for widespread administration. With this vision, he embarked on a journey to create a groundbreaking solution.
Dr. Sabin’s innovation involved using a live virus to develop the oral polio vaccine. He dedicated extensive time and effort to cultivate and test various strains of the polio virus. After numerous trials, he successfully identified three mutant strains that not only stimulated antibody production but also eliminated the risk of paralysis.
Dr. Albert Sabin’s oral polio vaccine revolutionized the prevention and control of this debilitating disease. Its ease of administration and effectiveness made it a game-changer in the global fight against polio.